Post Content Previous Post CAMS Q4 Results | Net profit, revenue up but margin shrinks; declares dividend of ₹19 per share Next Post Glenmark Pharma's relapsed cancer drug gets FDA 'fast track' status Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Post Comment
